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D4+CD25+ T regulatory cells, chronic liver disease and role in
mmunotherapy of HBV related hepatocellular cancer
. Trehanpati1,∗, S. Shrivastav2, S. Sarin3
Institute of Liver and Biliary Sciences, Delhi, India
Institute of Liver and Biliary Sciences, New Delhi, India
Institute Of Liver and Biliary Sciences, New Delhi, India
Background: CD4+CD25+ T regulatory (Treg) cells control
mmunologic tolerance to self-antigens and play a role in sup-
ressing antitumor immune responses, but the mechanism of
uppression in vivo remains uncertain. End stage liver diseases
hich include cirrhosis and hepatocellular carcinoma are becom-
ng leading cause of cancer-related mortality; HCC causes a poor
rognosis and limited survival. Therefore, better understanding
f the role of FOXP3 expressed regulatory T cells (Tregs) in HBV
elated hepatocellular carcinoma will provide a way to design of
uture immunotherapy-based clinical protocols for end stage liver
iseases.
Methods: We investigated Notch family gene expression in
eripheral blood and liver inﬁltrating lymphocytes(LIL) in the
athogenesis of HBV-related liver disease. Notch1 and FoxP3 pro-
ein expression on LIL and biopsieswas assessed by ﬂow cytometry
nd immunohistochemistry. HBV-speciﬁc CD8+ and CD4+ T cell
esponses were assessed by ﬂow cytometry. Student’s t-test was
sed to compare paired responses.
Results: In AVH-B, there was an increase in HBV speciﬁc CD8 T
ells proliferating than CD4 T cells. At both the protein and mRNA
evel, dual Notch1 and FoxP3 expression was signiﬁcantly higher
n cirrhotic PBMC, LIL and liver biopsies compared to HCC.In addi-
ion, reduced TGF-B expression was observed in cirrhotic and HCC
ompared to CHB.
Conclusion:Ourﬁndings suggest a novel involvement ofNotch-
signaling in the pathogenesis of chronic HBV induced liver
isease. On establishment of chronic HBV infection drives Notch
xpression and signaling up,which along with reduced TGF-B facil-
tates inﬁltration of FoXP3 expressing T cells into the liver resulting
n ﬁbrogenesis.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.121
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en year follow up of treatment of hepatitis C in intravenous
rug users
. Farley ∗, A. Truong, T. Nguyen, W. Shum
Dr John Farley Inc, Vancouver, BC, Canada
Background: Chronic Hepatitis C (HCV) is a frequent occur-
ence inintravenousdrugusers (IDU). Treatment ofHCV in IDUwith
urrently recommended treatment regimens is feasible and effec-
ive. There is little data on long term follow up of IDU treated fornfectious Diseases 16S (2012) e2–e157 e49
HCV. This study addresses this deﬁciency and is based on real life
community- based clinical setting.
Methods: Retrospective medical chart review of 585 indi-
viduals with admitted IDU and treated for HCV with pegylated
interferon- 2a/2b (PEG-IFN) and weight-based ribavirin between
December 2000 and November 2010. Treatment was based on cur-
rent recommended treatmet regimen (standards of care) through
consulting services offered by two community-based clinics in
British Columbia. Some received treatment in correctional institu-
tions either entirely or at some timeduring the course of treatment.
The treatmetwashowever supervisedby the twocommunitybased
clinics.
Results: 585 individuals: 88.2% males (516/585) mean age 40.6
± 9.01, 11.8% females (69/585) mean age 42.0 ± 9.52. Of those
with relevant data, 74.7% (437/585) were treated in prison, 25.3%
(148/585) were treated in the community. Total admitted IDU his-
tory 100% (585/585). SVR (ITT analysis) by genotype: Geno 1: 44.9%
(150/334); Geno 2 :71.4% (40/56); Geno 3: 83% (140/188); Other
Genotypes: 57.1% (4/7). Re-infection occurred in 14.2% (62/437);
Reinfection was more likely to occur amongst inmates (or former
inmates) 1.4% (2/148) in non-inmates, P=0.000, OR 11.82, CI Lower
3.1 and CI Higher 101.1. 3.2% (19/585) deceased.
Conclusion: TreatingHCV amongst IDU is feasible and effective.
SVR rates were consistent with non-IDU populations. Genotypes 2
& 3 had higher rates of SVR than genotye 1. Re-infections occurred
mostly in inmates of correctional institutions. Addressing addic-
tions is important before, during and after treatment is important
for maintainance of SVR. 3.2% of individuals we followed died. This
number is likely underestimated as many were lost to follow up.
Efforts must be made to reach and treat vulnerable populations
sooner to prevent further spread of disease and increase treat-
ment success. Sucessful treatment programs for HCV in IDU must
include on-going management of addictions, and regular health-
care engagements.
http://dx.doi.org/10.1016/j.ijid.2012.05.122
Type: Oral Presentation
Final Abstract Number: 28.006
Session: New Developments in Viral Diseases
Date: Friday, June 15, 2012
Time: 15:45-17:45
Room: Lotus 11
Epidemiological signiﬁcance of non-glycosylated Asn residues
found in the hemagglutinin protein of the H1N1 inﬂuenza virus
from 1918 to 2012
M. Cueno ∗, K. Ochiai
Nihon University School of Dentistry, Tokyo, Japan
Background: Inﬂuenza A virus hemagglutinin (HA) consists
of a head (HA1) and stem (HA2) where certain non-glycosylated
asparagine (Asn) residues contribute to protein stabilization and
to overall protein conformation which can inﬂuence both the evo-
lution and pathogenicity of the inﬂuenza virus. This suggests that
non-glycosylated Asn residues play a signiﬁcant role in HA, making
it a good focus for epidemiological studies, however, no study have
been made to date.
Methods: We analyzed 2,830 H1N1 HA sequences and focused
our study on non-glycosylated Asn415/416 and Asn472-473
residues found within the H1N1 strains circulating through 1918-
2012. Frequency of Asn residues originating from human, avian
and swine were established. We used the I-Tasser, HCA and Phyre
